The customer, a top chemical industry company with a global presence and headquarters in Europe, has been a loyal SenzaGen customer for several years. This testing project aims to establish safe dose levels and assess the risks of specialty chemicals in their product development processes. This new order further strengthens the position of the GARD® technology among leading global customers:

"We are extremely pleased to receive yet another important order from this loyal chemical industry client. This new order confirms that our organic growth strategy continues to deliver excellent results. We not only attract new clients but also build long-term relationships and expand our business with existing ones, creating a foundation for sustained growth. Additionally, this order focuses on GARD®skin Dose-Response, a product we are actively working to broaden in its applications as we pursue OECD approval," says Peter Nählstedt, CEO and Group President of SenzaGen.

The test method GARD®skin Dose-Response is a unique test method that provides quantitative data replacing the need for animal testing to establish safe dose levels of skin sensitizing substances in products. This provides companies in industries such as cosmetics, pharmaceuticals, and chemicals with crucial data for prioritization and decision-making in the research and development of new products.